249 related articles for article (PubMed ID: 27852006)
21. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
Rudolf Z; Strojan P
Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
[TBL] [Abstract][Full Text] [Related]
22. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death.
Sharma KV; Davids LM
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):156-63. PubMed ID: 22594986
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O
J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
[TBL] [Abstract][Full Text] [Related]
25. Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma.
Hillner BE; Agarwala S; Middleton MR
J Clin Oncol; 2000 Apr; 18(7):1474-80. PubMed ID: 10735895
[TBL] [Abstract][Full Text] [Related]
26. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy in melanoma--an update.
Baldea I; Filip AG
J Physiol Pharmacol; 2012 Apr; 63(2):109-18. PubMed ID: 22653896
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy of metastatic melanoma: emerging trends and opportunities for a cure.
Pretto F; Neri D
Pharmacol Ther; 2013 Sep; 139(3):405-11. PubMed ID: 23711792
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
30. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
[TBL] [Abstract][Full Text] [Related]
31. Predictability of response to clinical thermochemotherapy by the clonogenic assay.
Mann BD; Storm FK; Morton DL; Bertelsen CA; Korn EL; Kaiser LR; Kern DH
Cancer; 1983 Oct; 52(8):1389-94. PubMed ID: 6616404
[TBL] [Abstract][Full Text] [Related]
32. Melanogenesis and DNA damage following photodynamic therapy in melanoma with two meso-substituted porphyrins.
Baldea I; Olteanu DE; Bolfa P; Tabaran F; Ion RM; Filip GA
J Photochem Photobiol B; 2016 Aug; 161():402-10. PubMed ID: 27314538
[TBL] [Abstract][Full Text] [Related]
33. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression.
Faião-Flores F; Quincoces Suarez JA; Fruet AC; Maria-Engler SS; Pardi PC; Maria DA
PLoS One; 2015; 10(3):e0118702. PubMed ID: 25742310
[TBL] [Abstract][Full Text] [Related]
34. Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.
Jiang G; Li RH; Sun C; Liu YQ; Zheng JN
PLoS One; 2014; 9(12):e111920. PubMed ID: 25502446
[TBL] [Abstract][Full Text] [Related]
35. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
36. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells.
Davids LM; Kleemann B; Kacerovská D; Pizinger K; Kidson SH
J Photochem Photobiol B; 2008 May; 91(2-3):67-76. PubMed ID: 18342534
[TBL] [Abstract][Full Text] [Related]
37. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
Busch C; Geisler J; Lillehaug JR; Lønning PE
Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
Zhao H; Yin R; Chen D; Ren J; Wang Y; Zhanga J; Deng H; Wang Y; Qiu H; Huang N; Zou Q; Zhao J; Gu Y
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):204-12. PubMed ID: 24534694
[TBL] [Abstract][Full Text] [Related]
39. Clinical and histopathologic findings after photodynamic therapy of choroidal melanoma.
Canal-Fontcuberta I; Salomão DR; Robertson D; Cantrill HL; Koozekanani D; Rath PP; Pulido JS
Retina; 2012 May; 32(5):942-8. PubMed ID: 22495329
[TBL] [Abstract][Full Text] [Related]
40. Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) - in vitro studies.
Szlasa W; Supplitt S; Drąg-Zalesińska M; Przystupski D; Kotowski K; Szewczyk A; Kasperkiewicz P; Saczko J; Kulbacka J
Biomed Pharmacother; 2020 Dec; 132():110883. PubMed ID: 33113417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
